OVERVIEW

Join nationally-renowned experts from Fred Hutchinson Cancer Center and UW Medicine for this accredited, multi-day, in-person symposium. This educational program will cover data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders. Learners will also have access to the session recordings and slides 4-6 weeks after the event. 

TARGET AUDIENCE

This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.

LEARNING OBJECTIVES

Upon completion of this activity, learners should be able to:

1. Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common malignant hematological diseases.
2. Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common solid tumor malignancies.
3. Integrate guideline-based treatments into clinical practice while personalizing care appropriately for the patient.
4. Integrate new therapeutic and diagnostic approaches into clinical practice as appropriate.

ACCREDITATION

The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Washington School of Medicine designates this live activity for a maximum of 39.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commaensurate with the extent of their participation in the activity.

For more information please visit the official event page.